Search for the latest oncology news by tumour type
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a…
The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical…
A new study finds substantial variation in the prevalence of triple-negative breast cancer among black…
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues…
A personalised prognosis for patients diagnosed with triple-negative breast cancer was the goal of a…
Chemotherapy for non-Hodgkin’s lymphomas is highly effective for most patients. In aggressive lymphomas, such as…
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer which is lethal to 15% of…
Multiple myeloma is the second most common haematological cancer, and despite significant progress in the…
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…